Can we leverage tax policy to improve public health?

Professor Lawrence Summers and former New York Mayor Michael Bloomberg announce a new task force to identify underused fiscal tools to mitigate health and economic burdens of non-communicable diseases (NCDs) in low and moderate income countries.

Prescription drugs in the United States can be quite costly, for both the government and individuals. New research from HKS professor Richard Zeckhauser offers a new framework for lowering the prices that are paid for a few extremely costly drugs.

From the John F. Kennedy Jr. Forum: Alternatives to the Affordable Care Act

Experts at Harvard Kennedy School address the pressing policy questions posed by the well-publicized calls to repeal and reform the country’s health care system, as well as the Trump administration’s and Congress’s less clearly defined approach to other programs for the poor.